Uterine (Endometrial) Cancer Clinical Trials

Doctors at Memorial Sloan Kettering are constantly working to improve treatment for endometrial (uterine) cancer through clinical trials. Participating in a clinical trial may give you access to treatments that are not widely available elsewhere.

Here you can find a continually updated listing of our current trials for endometrial cancer and other cancers of the uterus. To learn more about a study, choose from the list below.

15 Clinical Trials found

A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations

Diseases: Bladder Cancer, Breast Cancer, Head & Neck Cancer, Other, Lung Cancer, Small Cell, Mouth Cancer, Salivary Gland Cancer, Throat Cancer, Gastric Cancer, Uterine (Endometrial) Cancer
Locations: New York City, Westchester

A Phase I Study of Immunotherapy with IPH2201 plus Durvalumab in Patients with Metastatic Solid Tumors

Diseases: Cervical Cancer, Colon Cancer, Rectal Cancer, Pancreatic Cancer, Lung Cancer, Non-Small Cell, Ovarian Cancer, Metastatic Disease after Hormone-Reducing Therapy, Pancreatic Cancer, Uterine (Endometrial) Cancer
Locations: New York City

A Phase I/II Study of CX-2009 to Treat Patients with Inoperable or Metastatic Solid Tumors

Diseases: Breast Cancer, Head & Neck Cancer, Hepatobiliary, Lung Cancer, Non-Small Cell, Ovarian Cancer, Metastatic Disease after Hormone-Reducing Therapy, Throat Cancer, Upper Gastrointestinal, Uterine (Endometrial) Cancer
Locations: New York City, Westchester, Monmouth

A Phase I/II Study of Topical SOR007 in Patients with Skin Metastases from Cancer

Diseases: Adrenal Tumors, Bladder Cancer, Breast Cancer, Cervical Cancer, Germ Cell Tumors, Head & Neck Cancer, Pancreatic Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer, Thyroid Cancer, Gastric Cancer, Pancreatic Cancer, Uterine (Endometrial) Cancer
Locations: New York City

A Phase IB Study of ARQ 092 plus Other Anticancer Therapies in Patients with Recurrent or Persistent Solid Tumors

Diseases: Endometrial Cancer, Ovarian Cancer, Uterine (Endometrial) Cancer
Locations: New York City

A Phase II Study of Ado-Trastuzumab Emtansine in Patients with Cancers Driven by HER2

Diseases: Bladder Cancer, Colorectal Cancer, Colon Cancer, Rectal Cancer, Lung Cancer, Uterine (Endometrial) Cancer
Locations: New York City

A Phase II Study of Fulvestrant plus Abemaciclib in Recurrent or Persistent Hormone Receptor-Positive Endometrial Cancer

Diseases: Uterine (Endometrial) Cancer
Locations: New York City

A Phase II Study of Immunotherapy with Durvalumab Alone or with Tremelimumab in Women with Recurrent or Persistent Endometrial Cancer

Diseases: Endometrial Cancer, Uterine (Endometrial) Cancer
Locations: New York City, Commack, Basking Ridge, Rockville Centre, Westchester, Monmouth

A Phase II Study of Lenvatinib and Pembrolizumab Immunotherapy in Patients with Recurrent or Persistent Endometrial or Kidney Cancer

Diseases: Kidney Cancer, Uterine (Endometrial) Cancer
Locations: New York City, Commack, Basking Ridge, Westchester

A Phase II Study of LY3023414 to Treat Recurrent or Persistent Endometrial Cancer

Diseases: Uterine (Endometrial) Cancer
Locations: New York City, Commack, Basking Ridge, Rockville Centre, Westchester, Monmouth

People of MSK

People of MSK

{{{ _highlightResult.full_name.value }}}{{{ _highlightResult.degree.value }}}

{{{ _snippetResult.title.value }}}

{{{ _snippetResult.lay_title.value }}}

{{{ _highlightResult.full_name.value }}}{{{ _highlightResult.degree.value }}}

{{{ _highlightResult.full_name.value }}}{{{ _highlightResult.degree.value }}}

{{ formattedDate }} - {{{ _snippetResult.title.value }}}

{{{ _snippetResult.title.value }}}

Suggested Results (more)

Diseases (more)

Doctors (more)

Locations (more)

News and Stories (more)

Clinical Trials (more)

Research Labs (more)

Other Results (more)

A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations

A Phase I Study of Immunotherapy with IPH2201 plus Durvalumab in Patients with Metastatic Solid Tumors

A Phase I/II Study of CX-2009 to Treat Patients with Inoperable or Metastatic Solid Tumors

A Phase I/II Study of Topical SOR007 in Patients with Skin Metastases from Cancer

A Phase IB Study of ARQ 092 plus Other Anticancer Therapies in Patients with Recurrent or Persistent Solid Tumors

A Phase II Study of Ado-Trastuzumab Emtansine in Patients with Cancers Driven by HER2

A Phase II Study of Fulvestrant plus Abemaciclib in Recurrent or Persistent Hormone Receptor-Positive Endometrial Cancer

A Phase II Study of Immunotherapy with Durvalumab Alone or with Tremelimumab in Women with Recurrent or Persistent Endometrial Cancer

A Phase II Study of Lenvatinib and Pembrolizumab Immunotherapy in Patients with Recurrent or Persistent Endometrial or Kidney Cancer

A Phase II Study of LY3023414 to Treat Recurrent or Persistent Endometrial Cancer